trial · primary record
Vericiguat tablet
Heart Failure
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 342 |
| Primary completion | 2032-05-12 |
| Primary endpoint | Base Period: Change from baseline to Week 16 in N-terminal pro-brain natriuretic peptide (NT-proBNP) |
| Registry ID | NCT05714085 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:05.545Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05714085
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.